Regeneron Pharmaceuticals News

Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director RYAN ARTHUR F

Apr 3 16:10 ET

Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer McCourt Marion

Apr 3 16:10 ET

Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 1 16:36 ET

Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer MURPHY ANDREW J

Mar 15 16:07 ET

Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 14 16:38 ET

Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director RYAN ARTHUR F

Mar 5 16:03 ET

Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer McCourt Marion

Mar 5 16:03 ET

Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 1 16:19 ET

Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer LAROSA JOSEPH J

Feb 28 16:10 ET

Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SING GEORGE L

Feb 28 16:09 ET

Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer STAHL NEIL

Feb 28 16:08 ET

Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 26 16:37 ET

Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Bassler Bonnie L

Feb 26 16:12 ET

Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer LAROSA JOSEPH J

Feb 26 16:12 ET

Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 26 16:12 ET

Regeneron Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SING GEORGE L

Feb 26 16:11 ET

Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 26 15:27 ET

Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 23 16:10 ET

Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 22 17:13 ET

Regeneron Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 22 16:11 ET